Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Harvard Bioscience (HBIO) Return on Invested Capital (2016 - 2025)

Historic Return on Invested Capital for Harvard Bioscience (HBIO) over the last 15 years, with Q3 2025 value amounting to 1.02%.

  • Harvard Bioscience's Return on Invested Capital fell 9600.0% to 1.02% in Q3 2025 from the same period last year, while for Sep 2025 it was 1.02%, marking a year-over-year decrease of 9600.0%. This contributed to the annual value of 0.06% for FY2024, which is 900.0% down from last year.
  • Harvard Bioscience's Return on Invested Capital amounted to 1.02% in Q3 2025, which was down 9600.0% from 1.04% recorded in Q2 2025.
  • Harvard Bioscience's Return on Invested Capital's 5-year high stood at 0.08% during Q4 2021, with a 5-year trough of 1.04% in Q2 2025.
  • Its 5-year average for Return on Invested Capital is 0.16%, with a median of 0.02% in 2024.
  • As far as peak fluctuations go, Harvard Bioscience's Return on Invested Capital skyrocketed by 900bps in 2021, and later plummeted by -9900bps in 2025.
  • Harvard Bioscience's Return on Invested Capital (Quarter) stood at 0.08% in 2021, then crashed by -182bps to 0.06% in 2022, then soared by 137bps to 0.02% in 2023, then crashed by -381bps to 0.06% in 2024, then plummeted by -1485bps to 1.02% in 2025.
  • Its Return on Invested Capital stands at 1.02% for Q3 2025, versus 1.04% for Q2 2025 and 0.71% for Q1 2025.